Moscow described the talks as “very important” today Russiaand The European Union on the prospect of mutual recognition of vaccination certificates for the coronavirus, expressing the hope that the issue will be resolved soon.
“We consider the talks very important, the mutual recognition of the fact of vaccination is very important and must be institutionalized. Is essential “In order to remove unnecessary obstacles to the movement of our citizens,” said Dmitry Peshkov, a spokesman for the Russian president.
According to the APE BPE, Peshkov pointed out that both sides had questions on the technology of providing relevant information, but now “the work is carried out in a constructive mood, we hope that soon there will be results, that is the key”.
Earlier it was reported that the Russian Ministry of Health sent to the EU diplomatic mission. in Moscow “the required documentsrequested by the European side at the end of the bilateral consultations “.
The press service of the Ministry of Health pointed out that a representative of the delegation “confirmed their receipt on September 30“, As broadcast by the RIA-Novosti agency.
“In the phase of gradual evaluation by the EMA” Sputnik-V
The same agency clarified that the details of the visit of representatives of the European Medicines Agency to Russia (EMA) in the context of the certification process for the most widely known and used Russian vaccine Sputnik-V.
The Russian Foreign Minister Sergei Lavrov assessed that the cooperation with Coreper on the issue of Sputnik-V certification “has already been advanced enough, now we are in the phase of the so-called gradual evaluation” and during his meeting with representatives of the Federation of European Entrepreneurs of Russia stated that “it is important to resolve all these issues of recognition, mutual certification of vaccines on the basis of professional dialogue between experts in the field of health “.
THE Vladimir Gushin, director of the Gamaleya Institute, which produced Sputnik-V, said he and his colleagues believe the Russian vaccine will have completed the process of recognition by the World Health Organization (WHO), which is also in progress, by the end of November.
According to the Russian agency RIA-Novosti, which spoke with a representative of Coreper, the Agency can not comment on the planned or ongoing inspections at the production sites of each vaccine, as the process of gradual evaluation continues “until sufficient data is collected for the official application for a provisional registration certificate, which has not yet been lodged “.
It is recalled that Coreper has approved four Covid vaccines for use in Europe, of companies Pfizer/BioNTech, Modern, AstraZeneca and Johnson & Johnson, and controls five more under the “phasing-in” process: CureVac, Novavax, Sinovac, Vidprevtyn and Sputnik-V.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
